Holen Sie sich die Stockscreener-App
40.79
4.36%
-1.86
Vorhandelsmarkt:
40.43
-0.36
-0.88%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
TGTX stock hits fresh 52-week high – here’s why retail is bullish despite Q1 earnings miss - MSN
TG Therapeutics Stock Story Gains Interest In Nasdaq Index - Kalkine Media
TG Therapeutics' (NASDAQ:TGTX) Earnings Aren't As Good As They Appear - Yahoo Finance
TGTX Q1 earnings miss, sales rise Y/Y, stock up on raised 2026 view - MSN
Earnings call transcript: TG Therapeutics Q1 2026 misses EPS, stock surges - Investing.com UK
TG Therapeutics outlines $925M 2026 global revenue guidance while targeting ~$220M Q2 US BRIUMVI net revenue - MSN
Earnings call transcript: TG Therapeutics Q1 2026 misses EPS, stock surges By Investing.com - Investing.com Australia
Signal Says Which Biotech to Buy This Week - Schaeffer's Investment Research
A Look At TG Therapeutics (TGTX) Valuation After Record Q1 Revenue And Higher 2026 Guidance - Sahm
Why TG Therapeutics (TGTX) Is Up 27.4% After Raising 2026 Revenue Guidance On BRIUMVI Strength - Yahoo Finance
Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum - Yahoo Finance
TG THERAPEUTICS INC (NASDAQ:TGTX) Screens as Affordable Growth Play with Strong Revenue Surge and Discounted Valuation - ChartMill
MSN Money - MSN
TG Therapeutics (TGTX) Q1 2026 Results Put 66% Net Margin Narrative To The Test - Sahm
TG Therapeutics (TGTX) Q1 2026 Earnings Transcript - AOL.com
TGTX Stock Quote Price and Forecast - CNN
TGTX Reports Strong Q1 Revenue Growth and Upgraded Guidance - GuruFocus
TGTX Stock Price, Quote & Chart | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
Number of shareholders of TG Therapeutics, Inc. – LSX:A1JXW7 - TradingView
TG Therapeutics Stock 6-Day Winning Spree: Stock Climbs 28% - Trefis
6-Day Rally Sends TG Therapeutics Stock Up 28% - Trefis
TG Therapeutics Earnings Call Highlights Explosive Growth - The Globe and Mail
TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View - The Globe and Mail
Is Briumvi-Driven Earnings Growth Altering The Investment Case For TG Therapeutics (TGTX)? - Sahm
TG Therapeutics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
TG Therapeutics Reports First Quarter 2026 Financial Results and Raises BRIUMVI Revenue Guidance - marketscreener.com
TG Therapeutics, Inc. 2026 Q1 Financial Report – Key Risks, Commercialization, and Regulatory Updates - Minichart
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2026 Earnings Call Transcript - Insider Monkey
TG Therapeutics: Q1 Earnings Snapshot - theheraldreview.com
TG Therapeutics Q1 Earnings Call Highlights - Yahoo Finance
TGTX Forecast, Price Target & Analyst Ratings | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
TG Therapeutics Surges 11.3% After HC Wainwright & Co. Maintains Buy - AlphaStreet
TGTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TG Therapeutics, Inc. 1Q 2026: Revenue $204.92M, EPS $0.12— 10-Q Summary - TradingView
BRIUMVI sales lift TG Therapeutics (NASDAQ: TGTX) Q1 2026 results - Stock Titan
TG Therapeutics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
TG Therapeutics Releases Q1 2026 Financial Results - AlphaStreet
Tg therapeutics stock hits 52-week high at 41.24 USD - Investing.com
TG Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat
TG Therapeutics Up Over 14%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk - Moomoo
TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss - Stocktwits
0.96%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):